Reduced thalamic N-acetylaspartate in idiopathic normal pressure hydrocephalus: A controlled1H-magnetic resonance spectroscopy study of frontal deep white matter and the thalamus using absolute quantification

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 7, 2011, Pages 772-778

  Lundin, F ^a   Tisell, A ^a   Dahlqvist Leinhard, O ^a   Tullberg, M ^b   Wikkelso C ^b   Lundberg, P ^a,c   Leijon, G ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; BRAIN LEVEL; BRAIN METABOLISM; BRAIN WATER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IDIOPATHIC DISEASE; MALE; NORMOTENSIVE HYDROCEPHALUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; THALAMUS; WHITE MATTER;

AGED; AGED, 80 AND OVER; ASPARTIC ACID; BASAL GANGLIA; CEREBROVASCULAR DISORDERS; COGNITION; FEMALE; FRONTAL LOBE; GAIT DISORDERS, NEUROLOGIC; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; IMAGE PROCESSING, COMPUTER-ASSISTED; INTRACRANIAL PRESSURE; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEURAL PATHWAYS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; POSTURAL BALANCE; REGRESSION ANALYSIS; THALAMUS;

EID: 79959866076     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.223529     Document Type: Article

References (37)

1. Hakim S, Adams RD. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 1965;2:307-27.
2. Adams RD, Fisher CM, Hakim S, et al. Symptomatic occult hydrocephalus with 'Normal' cerebrospinal-fluid pressure. A treatable syndrome. N Engl J Med 1965;273:117-26.
3. Ojemann RG, Fisher CM, Adams RD, et al. Further experience with the syndrome of 'normal' pressure hydrocephalus. J Neurosurg 1969;31:279-94.
4. Hellström P, Edsbagge M, Archer T, et al. The neuropsychology of patients with clinically diagnosed idiopathic normal pressure hydrocephalus. Neurosurgery 2007;61:1219-26; discussion 1227-8.
5. Akai K, Uchigasaki S, Tanaka U, et al. Normal pressure hydrocephalus. Neuropathological study. Acta Pathol Jpn 1987;37:97-110.
6. Del Bigio MR. Neuropathological changes caused by hydrocephalus. Acta Neuropathol 1993;85:573-85. (Pubitemid 23212023)
7. Krauss JK, Regel JP, Vach W, et al. Vascular risk factors and arteriosclerotic disease in idiopathic normal-pressure hydrocephalus of the elderly. Stroke 1996;27:24-9.
8. Ross AJ, Sachdev PS. Magnetic resonance spectroscopy in cognitive research. Brain Res Brain Res Rev 2004;44:83-102. (Pubitemid 38293427)
9. Caramanos Z, Narayanan S, Arnold DL. 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. Brain 2005;128:2483-506. (Pubitemid 41552936)
10. Moffett JR, Ross B, Arun P, et al. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007;81:89-131. (Pubitemid 46282272)
11. De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995;34:721-7.
12. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993;15:289-98. (Pubitemid 24258162)
13. Relkin N, Marmarou A, Klinge P, et al. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 2005;57(3 Suppl):S4-16; discussion ii-v.
14. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state.' A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
15. Blomsterwall E, Svantesson U, Carlsson U, et al. Postural disturbance in patients with normal pressure hydrocephalus. Acta Neurol Scand 2000;102:284-91.
16. Podsiadlo D, Richardson S. The timed 'Up & Go': a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142-8.
17. Larsson A, Wikkelsö C, Bilting M, et al. Clinical parameters in 74 consecutive patients shunt operated for normal pressure hydrocephalus. Acta Neurol Scand 1991;84:475-82.
18. Provencher SW. Estimation of metabolite concentrations from localized in-vivo proton NMR spectra. Magn Reson Med 1993;30:672-9. (Pubitemid 23360802)
19. Kreis R, Ernst T, Ross BD. Absolute quantification of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson B 1993;102:9-19.
20. 1H MRS. NMR Biomed 2009;22:349-54.
21. 1H Magnetic Resonance Spectroscopy of Human Brain Using qMRI, Proceedings of ISMRM 17th Scientific Meeting and Exhibition. Honolulu, HI: 2009:18-24.
22. Ross AJ, Sachdev PS, Wen W, et al. Prediction of cognitive decline after stroke using proton magnetic resonance spectroscopy. J Neurol Sci 2006;251:62-9. (Pubitemid 44792140)
23. Ross AJ, Sachdev PS, Wen W, et al. Cognitive correlates of 1H MRS measures in the healthy elderly brain. Brain Res Bull 2005;66:9-16. (Pubitemid 40733107)
24. Braun KP, Gooskens RH, Vandertop WP, et al. 1H magnetic resonance spectroscopy in human hydrocephalus. J Magn Reson Imaging 2003;17:291-9. (Pubitemid 36259242)
25. Lenfeldt N, Hauksson J, Birgander R, et al. Improvement after cerebrospinal fluid drainage is related to levels of N-acetyl-aspartate in idiopathic normal pressure hydrocephalus. Neurosurgery 2008;62:135-41. discussion 141-2.
26. del Mar Matarín M, Pueyo R, Poca MA, et al. Post-surgical changes in brain metabolism detected by magnetic resonance spectroscopy in normal pressure hydrocephalus: results of a pilot study. J Neurol Neurosurg Psychiatry 2007;78:760-3. (Pubitemid 46998855)
27. Soares DP, Law M. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol 2009;64:12-21.
28. Maudsley AA, Domenig C, Govind V, et al. Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI). Magn Reson Med 2009;61:548-59.
29. Li BS, Wang H, Gonen O. Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging 2003;21:923-8. (Pubitemid 37377485)
30. Schirmer T, Auer DP. On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR Biomed 2000;13:28-36. (Pubitemid 30136999)
31. Halliday GM. Thalamic changes in Parkinson's disease. Parkinsonism Relat Disord 2009;(15 Suppl 3):S152-5.
32. Henderson JM, Carpenter K, Cartwright H, et al. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Brain 2000;123:1410-21. (Pubitemid 30420941)
33. Jakary A, Vinogradov S, Feiwell R, et al. N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI. Schizophr Res 2005;76:173-85. (Pubitemid 40804764)
34. Ruocco HH, Lopes-Cendes I, Li LM, et al. Evidence of thalamic dysfunction in Huntington disease by proton magnetic resonance spectroscopy. Mov Disord 2007;22:2052-6.
35. Owler BK, Pickard JD. Normal pressure hydrocephalus and cerebral blood flow: a review. Acta Neurol Scand 2001;104:325-42. (Pubitemid 33105105)
36. Owler BK, Momjian S, Czosnyka Z, et al. Normal pressure hydrocephalus and cerebral blood flow: a PET study of baseline values. J Cereb Blood Flow Metab 2004;24:17-23. (Pubitemid 38021265)
37. Vrenken H, Barkhof F, Uitdehaag BM, et al. MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Magn Reson Med 2005;53:256-66. (Pubitemid 40171039)